Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Canaccord Genuity analyst Doug Taylor maintains WELL Health Technologies (TSX:WELL) with a Buy and maintains C$7 price target.
Scotiabank analyst Adam Buckham maintains WELL Health Technologies (TSX:WELL) with a Sector Outperform and lowers the price ...
RBC Capital analyst Douglas Miehm reiterates WELL Health Technologies (TSX:WELL) with a Outperform and maintains C$5.5 price...
RBC Capital analyst Douglas Miehm initiates coverage on WELL Health Technologies (TSX:WELL) with a Outperform rating and ann...
Raymond James analyst Rahul Sarugaser initiates coverage on WELL Health Technologies (TSX:WELL) with a Outperform rating and...
Scotiabank upgrades WELL Health Technologies (TSX:WELL) from Sector Perform to Sector Outperform.
WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and mod...
TD Securities maintains WELL Health Technologies (TSX:WELL) with a Buy and lowers the price target from C$10.5 to C$9.5.
